Gordon C. Jayson

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

Sean Kehoe, Jane Hook, Matthew Nankivell et al. · The Lancet · 2015 · 1.4K citations

Medicine, Oncology, Surgery +14

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

Mahesh Parmar, Jonathan A. Ledermann, Nicoletta Colombo et al. · The Lancet · 2003 · 1.2K citations

Medicine, Gynecology, Oncology +17

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Amit M. Oza, Adrian Cook, Jacobus Pfisterer et al. · The Lancet Oncology · 2015 · 867 citations · Full text

Medicine, Gynecology, Oncology +15

Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI

Geoff J.M. Parker, Caleb Roberts, Andrew Macdonald et al. · Magnetic Resonance in Medicine · 2006 · 664 citations · Full text

Medicine, Oncology, Radiology +12

Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

P. Vasey, Gordon C. Jayson, Amanda Gordon et al. · JNCI Journal of the National Cancer Institute · 2004 · 638 citations · Full text

Medicine, Oncology, Pharmacology +16